Skip to main content
SpringerLink
Log in

MIBG imaging for selecting heart failure patients for defibrillator therapy: A first step

  • Published:
Journal of Nuclear Cardiology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Levy D, Kenchaiah S, Larson MG, et al. Long term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397–402.

    Article  PubMed  Google Scholar 

  2. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877–83.

    Article  PubMed  Google Scholar 

  3. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmic devices-summary article. J Am Coll Cardiol 2002;40:1703–19.

    Article  PubMed  Google Scholar 

  4. Feldman A, Bristow M, Reese A, et al. Webcast news release for the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure trial (COMPANION). Available at: www.guidant. com/webcast/. November 21, 2002. Accessed December 6, 2002.

  5. Klein H, Auricchio A, Reek S, et al. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. Am J Cardiol 1999;83:91D-97D.

    Article  PubMed  CAS  Google Scholar 

  6. Kadish A, Quigg R, Schaechter M, et al. Defibrillators in nonischemic cardiomyopathy treatment evaluation. Pacing Clin Electrophysiol 2000;23:338–43.

    Article  PubMed  CAS  Google Scholar 

  7. Arora R, Ferrick KJ, Nakata T, et al. I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator. J Nucl Cardiol 2003;10:

  8. Tomodo H, Yoshioka K, Shiina Y, et al. Regional sympathetic deinnervation detected by I-123 metaiodobenzylguanidine in non- Q-wave myocardial infarction and unstable angina. Am Heart J 1994;128:452–8.

    Article  Google Scholar 

  9. Stanton MS, Tuli MM, Radtke NI, et al. Regional sympathetic deinnervation after myocardial infarction in humans detected non-invasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol 1989;14:1519–26.

    Article  PubMed  CAS  Google Scholar 

  10. McGhie AI, Corbett JR, Akers MS, et al. Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction. Am J Cardiol 1991;67:236–42.

    Article  PubMed  CAS  Google Scholar 

  11. Dae MW, Herre JM, O’Connell JW, et al. Scintigraphic assessment of sympathetic innervation after transmural versus non-transmural infarction. J Am Coll Cardiol 1991;17:1416–23.

    Article  PubMed  CAS  Google Scholar 

  12. Kammerling JJ, Green FJ, Watanabe AM, et al. Denervation supersensitivity of refractoriness in noninfarcted areas apical to transmural myocardial infarction. Circulation 1987;76:383–93.

    PubMed  CAS  Google Scholar 

  13. Imamura Y, Ando H, Mitsuoka W, et al. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol 1995;26:1594–9.

    Article  PubMed  CAS  Google Scholar 

  14. Merlet P, Pouillart F, Dubois-Rande JL, et al. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart. J Nucl Med 1999;40:224–31.

    PubMed  CAS  Google Scholar 

  15. Carrió I. Cardiac neurotransmission imaging. J Nucl Med 2001; 42:1062–76.

    PubMed  Google Scholar 

  16. Bohm M, La Rosee K, Schwinger RH, et al. Evidence for reduction of norepinephrine uptake sites in the failing heart. J Am Coll Cardiol 1995;25:146–53.

    Article  PubMed  CAS  Google Scholar 

  17. Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing hearts. N Engl J Med 1982;307:205–11.

    PubMed  CAS  Google Scholar 

  18. Merlet P, Valette H, Dubois-Rande JL, et al. Prognostic value of cardiac meta-iodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471–7.

    PubMed  CAS  Google Scholar 

  19. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976;294:1165–70.

    PubMed  CAS  Google Scholar 

  20. Bigger JT Jr, Fleiss JL, Steinman RC, et al. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85:164–71.

    PubMed  Google Scholar 

  21. Zuanetti G, Neilson JMM, Latini R, et al, on behalf of GISSI-2 investigators. Prognostic significance of heart rate variability in postmyocardial infarction patients in the fibrinolytic era. Circulation 1996;94:432–6.

    PubMed  CAS  Google Scholar 

  22. Szabo BM, van Veldhuisen DJ, van der Veer N, et al. Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 1997;79:978–80.

    Article  PubMed  CAS  Google Scholar 

  23. Jiang W, Hathaway WR, McNulty S, et al. Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure. Am J Cardiol 1997;80:808–11.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Tufts-New England Medical Center, 750 Washington St, Box 70, 02111, Boston, MA

    Colin D. Shafer & James E. Udelson

Authors
  1. Colin D. Shafer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James E. Udelson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James E. Udelson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shafer, C.D., Udelson, J.E. MIBG imaging for selecting heart failure patients for defibrillator therapy: A first step. J Nucl Cardiol 10, 208–210 (2003). https://doi.org/10.1067/mnc.2003.393

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1067/mnc.2003.393

Search

Navigation